HEALTHBANK Trademark

Trademark Overview


On Friday, May 23, 2025, a trademark application was filed for HEALTHBANK with the United States Patent and Trademark Office. The USPTO has given the HEALTHBANK trademark a serial number of 99199401. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, April 23, 2026. The HEALTHBANK trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Immune cells, namely, cells for scientific, laboratory or medical research; tissue cells, namely, cells for scientific, laboratory or medical research; biological tissues, namely, stem cells, progenitor cells, immune cells, tumor cells, blood-derived cells, stromal cells, connective tissue, support tissue, organ tissue, adipose and soft tissue, vascular tissue, skin and surface tissues, mucosal tissue, neural tissue, decellularized tissue, demineralized tissue, umbilical cords, placentas, bone marrow and tumor tissue for scientific, laboratory and medical research use; derivatives of immune cells, tissue cells, and biological tissues, namely, proteins, peptides substrates, enzymes, cellular cytokines, chemokines, monoclonal antibodies, DNA vectors, RNA, growth factors, cell lysate, extracellular matrix and conditioned media for growing cells for scientific, laboratory or medical research

Immune cells, namely, cells for medical or veterinary use; tissue cells, namely, cells for medical or veterinary use; biological tissues cultures, namely, stem cells, progenitor cells, immune cells, tumor cells, blood-derived cells, stromal cells, connective tissue, support tissue, organ tissue, adipose and soft tissue, vascular tissue, skin and surface tissues, mucosal tissue, neural tissue, decellularized tissue, demineralized tissue, umbilical cords, placentas, bone marrow and tumor tissue for medical or veterinary use; derivatives of immune cells, tissue cells, and biological tissues, namely, vaccines, proteins, peptides substrates, cellular cytokines, chemokines, monoclonal antibodies, DNA vectors, RNA, growth factors, cell lysate, extracellular matrix, and conditioned media for medical or veterinary use.
healthbank

General Information


Serial Number99199401
Word MarkHEALTHBANK
Filing DateFriday, May 23, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, April 23, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 12, 2026

Trademark Statements


Goods and ServicesImmune cells, namely, cells for scientific, laboratory or medical research; tissue cells, namely, cells for scientific, laboratory or medical research; biological tissues, namely, stem cells, progenitor cells, immune cells, tumor cells, blood-derived cells, stromal cells, connective tissue, support tissue, organ tissue, adipose and soft tissue, vascular tissue, skin and surface tissues, mucosal tissue, neural tissue, decellularized tissue, demineralized tissue, umbilical cords, placentas, bone marrow and tumor tissue for scientific, laboratory and medical research use; derivatives of immune cells, tissue cells, and biological tissues, namely, proteins, peptides substrates, enzymes, cellular cytokines, chemokines, monoclonal antibodies, DNA vectors, RNA, growth factors, cell lysate, extracellular matrix and conditioned media for growing cells for scientific, laboratory or medical research
Pseudo MarkHEALTH BANK
Goods and ServicesImmune cells, namely, cells for medical or veterinary use; tissue cells, namely, cells for medical or veterinary use; biological tissues cultures, namely, stem cells, progenitor cells, immune cells, tumor cells, blood-derived cells, stromal cells, connective tissue, support tissue, organ tissue, adipose and soft tissue, vascular tissue, skin and surface tissues, mucosal tissue, neural tissue, decellularized tissue, demineralized tissue, umbilical cords, placentas, bone marrow and tumor tissue for medical or veterinary use; derivatives of immune cells, tissue cells, and biological tissues, namely, vaccines, proteins, peptides substrates, cellular cytokines, chemokines, monoclonal antibodies, DNA vectors, RNA, growth factors, cell lysate, extracellular matrix, and conditioned media for medical or veterinary use.

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, May 23, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 23, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressBethesda, MD 20814
US

Trademark Events


Event DateEvent Description
Friday, May 23, 2025NEW APPLICATION ENTERED
Friday, May 23, 2025APPLICATION FILING RECEIPT MAILED
Thursday, October 2, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 9, 2025ASSIGNED TO EXAMINER
Friday, October 17, 2025NON-FINAL ACTION WRITTEN
Friday, October 17, 2025NON-FINAL ACTION E-MAILED
Friday, October 17, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 7, 2026APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, January 7, 2026APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, April 15, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 15, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 15, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 16, 2026APPROVED FOR PUB - PRINCIPAL REGISTER